Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bo Cen, Ying Xiong, Jin H. Song, Sandeep Mahajan, Rachel DuPont, Kristen McEachern, Daniel J. DeAngelo, Jorge E. Cortes, Mark D. Minden, Allen Ebens, Alice Mims, Amanda C. LaRue & Andrew S. Kraft. (2014) The Pim-1 Protein Kinase Is an Important Regulator of MET Receptor Tyrosine Kinase Levels and Signaling. Molecular and Cellular Biology 34:13, pages 2517-2532.
Read now
Read now
Articles from other publishers (54)
Weiquan Zhang, Tao Chen, Peilin Yang, Xiaolan Li, Dan Zhu, Zhiheng Su, Xin Yang, Ronghua Jin, Taijin Lan & Hongwei Guo. (2024) Total flavonoids of Litchi chinensis Sonn. seed inhibit prostate cancer growth in bone by regulating the bone microenvironment via inactivation of the HGFR/NF-κB signaling pathway. Journal of Ethnopharmacology 319, pages 117327.
Crossref
Crossref
Larsson Anders, Carlsson Lena, Khierallah Rasha, Holte Jan & Kallak Theodora Kunovac. (2023) Higher levels of Hepatocyte Growth Factor (HGF) in human seminal plasma in comparison with blood plasma and negative association with several motile sperm cells. Global Journal of Fertility and Research 8:1, pages 008-013.
Crossref
Crossref
Jin Hui Teh, Ala Amgheib, Ruisi Fu, Chris Barnes, Joel Abrahams, Ali Ashek, Ning Wang, Zixuan Yang, Muneera Mansoorudeen, Nicholas J. Long & Eric O. Aboagye. (2023) Evaluation of [18F]AlF-EMP-105 for Molecular Imaging of C-Met. Pharmaceutics 15:7, pages 1915.
Crossref
Crossref
Mini Dahiya, Monu Yadav, Pratibha Sharma & Anil Kumar. 2023. Handbook of Oncobiology: From Basic to Clinical Sciences. Handbook of Oncobiology: From Basic to Clinical Sciences
1
22
.
Jinyuan Chang, Zhenglong Jiang, Tianyu Ma, Jie Li, Jiayang Chen, Peizhi Ye & Li Feng. (2022) Integrating transcriptomics and network analysis-based multiplexed drug repurposing to screen drug candidates for M2 macrophage-associated castration-resistant prostate cancer bone metastases. Frontiers in Immunology 13.
Crossref
Crossref
Vinay Kumar, Pavneet Randhawa, Robert Bilodeau, Dan Mercola, Michael McClelland, Anshu Agrawal, James Nguyen, Patricia Castro, Michael M. Ittmann & Farah Rahmatpanah. (2022) Spatial Profiling of the Prostate Cancer Tumor Microenvironment Reveals Multiple Differences in Gene Expression and Correlation with Recurrence Risk. Cancers 14:19, pages 4923.
Crossref
Crossref
Manon Baures, Emilia Puig Lombardi, Delphine Di Martino, Wail Zeitouni, Emeline Pacreau, Leïla Dos Santos, Charles Dariane, Florence Boutillon, Jacques-Emmanuel Guidotti & Vincent Goffin. (2022) Transcriptomic Signature and Growth Factor Regulation of Castration-Tolerant Prostate Luminal Progenitor Cells. Cancers 14:15, pages 3775.
Crossref
Crossref
Nezihi Murat Karabacak, Yu Zheng, Taronish D. Dubash, Risa Burr, Douglas S. Micalizzi, Ben S. Wittner, Maoxuan Lin, Devon F. Wiley, Valentine Comaills, Erin Emmons, Kira L. Niederhoffer, Uyen Ho, Jacob Ukleja, Dante Che, Hannah Stowe, Linda T. Nieman, Wilhelm Haas, Shannon L. Stott, Michael S. Lawrence, David T. Ting, David T. Miyamoto, Daniel A. Haber, Mehmet Toner & Shyamala Maheswaran. (2022) Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition. Cancer Research 82:6, pages 1084-1097.
Crossref
Crossref
Austin McDermott, KyoungHyun Kim, Susan Kasper, Shuk-Mei Ho & Yuet-Kin Leung. (2022) The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells. Oncotarget 13:1, pages 46-60.
Crossref
Crossref
Chung Hyo Kang, Yeongrin Kim, Da Yeon Lee, Sang Un Choi, Heung Kyoung Lee & Chi Hoon Park. (2021) c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer. Cancers 13:22, pages 5738.
Crossref
Crossref
Haixiang Qin, Yang Yang, Bo Jiang, Chun Pan, Wei Chen, Wenli Diao, Meng Ding, Wenmin Cao, Zhenxing Zhang, Mengxia Chen, Jie Gao, Xiaozhi Zhao, Xuefeng Qiu & Hongqian Guo. (2021) SOX9 in prostate cancer is upregulated by cancer‐associated fibroblasts to promote tumor progression through HGF/c‐Met‐FRA1 signaling. The FEBS Journal 288:18, pages 5406-5429.
Crossref
Crossref
Yutaka Fujiwara, Hirotsugu Kenmotsu, Noboru Yamamoto, Toshio Shimizu, Kan Yonemori, Christopher Ocampo, Apurvasena Parikh, Sumiko Okubo, Kazuteru Fukasawa & Haruyasu Murakami. (2021) Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors. Cancer Medicine 10:7, pages 2350-2358.
Crossref
Crossref
Natalie Silk, Jeremy Reich, Rahul Sinha, Shivansh Chawla, Kyla Geary & Dianzheng Zhang. (2021) The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment. Journal of Xenobiotics 11:1, pages 16-32.
Crossref
Crossref
Anantha N. Nagappa, Shvetank Bhatt & Jovita Kanoujia. (2020) Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors. Current Enzyme Inhibition 16:1, pages 90-105.
Crossref
Crossref
Clara H. Lee, Ann M. Decker, Frank C. Cackowski & Russell S. Taichman. (2019) Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer. Cell Biology and Toxicology 36:2, pages 115-130.
Crossref
Crossref
Joseph Aldahl, Jiaqi Mi, Ariana Pineda, Won Kyung Kim, Adam Olson, Erika Hooker, Yongfeng He, Eun-Jeong Yu, Vien Le, Dong-Hoon Lee, Joseph Geradts & Zijie Sun. (2020) Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin–mediated prostatic tumorigenesis. Journal of Biological Chemistry 295:2, pages 631-644.
Crossref
Crossref
Jordan E. Vellky, Tyler M. Bauman, Emily A. Ricke, Wei Huang & William A. Ricke. (2019) Incidence of androgen receptor and androgen receptor variant 7 coexpression in prostate cancer. The Prostate 79:16, pages 1811-1822.
Crossref
Crossref
Shuai Gao, Sujun Chen, Dong Han, David Barrett, Wanting Han, Musaddeque Ahmed, Susan Patalano, Jill A. Macoska, Housheng Hansen He & Changmeng Cai. (2019) Forkhead domain mutations in FOXA1 drive prostate cancer progression. Cell Research 29:9, pages 770-772.
Crossref
Crossref
Ramona Willbold, Katharina Wirth, Thomas Martini, Holger Sültmann, Christian Bolenz & Rainer Wittig. (2019) Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells. Cell Death & Disease 10:8.
Crossref
Crossref
Siqi Zhang, Qiaoling Song, Xueting Wang, Zhiqiang Wei, Rilei Yu, Xin Wang & Tao Jiang. (2019) Virtual Screening Guided Design, Synthesis and Bioactivity Study of Benzisoselenazolones (BISAs) on Inhibition of c-Met and Its Downstream Signalling Pathways. International Journal of Molecular Sciences 20:10, pages 2489.
Crossref
Crossref
Jiaqi Mi, Erika Hooker, Steven Balog, Hong Zeng, Daniel T. Johnson, Yongfeng He, Eun-Jeong Yu, Huiqing Wu, Vien Le, Dong-Hoon Lee, Joseph Aldahl, Mark L. Gonzalgo & Zijie Sun. (2018) Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate. Journal of Biological Chemistry 293:52, pages 20123-20136.
Crossref
Crossref
Qidong Tang, Yongli Duan, Hehua Xiong, Ting Chen, Zhen Xiao, Linxiao Wang, Yueyue Xiao, Shunmin Huang, Yinhua Xiong, Wufu Zhu, Ping Gong & Pengwu Zheng. (2018) Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety. European Journal of Medicinal Chemistry 158, pages 201-213.
Crossref
Crossref
Changki Lee, Young Mi Whang, Preston Campbell, Patrick L. Mulcrone, Florent Elefteriou, Sun Wook Cho & Serk In Park. (2018) Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis. Cancer Letters 414, pages 205-213.
Crossref
Crossref
Martin Chevrier, Diwakar Bobbala, Alberto Villalobos-Hernandez, Md Gulam Musawwir Khan, Sheela Ramanathan, Caroline Saucier, Gerardo Ferbeyre, Sameh Geha & Subburaj Ilangumaran. (2017) Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer. BMC Cancer 17:1.
Crossref
Crossref
W-Y Chen, Y-C Tsai, M K Siu, H-L Yeh, C-L Chen, J J Yin, J Huang & Y-N Liu. (2017) Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis. Oncogene 36:45, pages 6213-6224.
Crossref
Crossref
Thomas Kryza, Lakmali M. Silva, Nathalie Bock, Ruth A. Fuhrman‐Luck, Carson R. Stephens, Jin Gao, Hema Samaratunga, Mitchell G. Lawrence, John D. Hooper, Ying Dong, Gail P. Risbridger & Judith A. Clements. (2017) Kallikrein‐related peptidase 4 induces cancer‐associated fibroblast features in prostate‐derived stromal cells. Molecular Oncology 11:10, pages 1307-1329.
Crossref
Crossref
A Cannistraci, G Federici, A Addario, A L Di Pace, L Grassi, G Muto, D Collura, M Signore, L De Salvo, S Sentinelli, G Simone, M Costantini, S Nanni, A Farsetti, V Coppola, R De Maria & D Bonci. (2017) C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition. Oncogene 36:26, pages 3718-3728.
Crossref
Crossref
Kalevi Kairemo, Gregory C. Ravizzini, Homer A. Macapinlac & Vivek Subbiah. (2017) An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prostate Adenocarcinoma. Diagnostics 7:2, pages 20.
Crossref
Crossref
A Villalobos-Hernandez, D Bobbala, R Kandhi, M G M Khan, M Mayhue, C M Dubois, G Ferbeyre, C Saucier, S Ramanathan & S Ilangumaran. (2016) SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma. Prostate Cancer and Prostatic Diseases 20:1, pages 36-47.
Crossref
Crossref
R. B. Marques, C. M. A. de Ridder & W. M. van Weerden. 2017. Patient-Derived Mouse Models of Cancer. Patient-Derived Mouse Models of Cancer
89
112
.
Janet C. Reid, Nigel C. Bennett, Carson R. Stephens, Melanie L. Carroll, Viktor Magdolen, Judith A. Clements & John D. Hooper. (2016)
In vitro
evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B
. Biological Chemistry 397:12, pages 1299-1305.
Crossref
Crossref
Farshid Dayyani, Amado J. Zurita, Graciela M. Nogueras-González, Rebecca Slack, Randall E. Millikan, John C. Araujo, Gary E. Gallick, Christopher J. Logothetis & Paul G. Corn. (2016) The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study. BMC Cancer 16:1.
Crossref
Crossref
Sofia Halin Bergström, Christina Hägglöf, Elin Thysell, Anders Bergh, Pernilla Wikström & Marie Lundholm. (2016) Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth. Scientific Reports 6:1.
Crossref
Crossref
Mohamed M. Mohyeldin, Belnaser A. Busnena, Mohamed R. Akl, Ana Maria Dragoi, James A. Cardelli & Khalid A. El Sayed. (2016) Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer. European Journal of Medicinal Chemistry 118, pages 299-315.
Crossref
Crossref
Marco Lo Iacono, Consuelo Buttigliero, Valentina Monica, Enrico Bollito, Diletta Garrou, Susanna Cappia, Ida Rapa, Francesca Vignani, Valentina Bertaglia, Cristian Fiori, Mauro Papotti, Marco Volante, Giorgio V. Scagliotti, Francesco Porpiglia & Marcello Tucci. (2016) Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer. Oncotarget 7:12, pages 14394-14404.
Crossref
Crossref
HUI-JUN HU, XIAO-LONG LIN, MI-HUA LIU, XIAO-JUAN FAN & WEI-WEN ZOU. (2016) Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells. Oncology Letters 11:2, pages 1499-1505.
Crossref
Crossref
Sven Perner, Marcus V. Cronauer, Andres Jan Schrader, Helmut Klocker, Zoran Culig & Aria Baniahmad. (2015) Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer. Oncotarget 6:34, pages 35542-35555.
Crossref
Crossref
Tanushree Chatterji, Andreas S. Varkaris, Nila U. Parikh, Jian H. Song, Chien-Jui Cheng, Rebecca E. Schweppe, Stephanie Alexander, John W. Davis, Patricia Troncoso, Peter Friedl, Jian Kuang, Sue-Hwa Lin & Gary E. Gallick. (2015) Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells. Oncotarget 6:12, pages 10175-10194.
Crossref
Crossref
GUO-SHENG WANG, JIN-LONG ZHAO & HUAN LI. (2015) Treatment with Lingqi capsules suppresses colorectal cancer by inhibiting the hepatocyte growth factor/c-Met signal transduction pathway. Molecular Medicine Reports 11:3, pages 1865-1870.
Crossref
Crossref
W Xu, T Neill, Y Yang, Z Hu, E Cleveland, Y Wu, R Hutten, X Xiao, S R Stock, D Shevrin, K Kaul, C Brendler, R V Iozzo & P Seth. (2014) The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer. Gene Therapy 22:3, pages 247-256.
Crossref
Crossref
Anna Spina, Valeria De Pasquale, Giuliana Cerulo, Pasquale Cocchiaro, Rossella Della Morte, Luigi Avallone & Luigi Pavone. (2015) HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation. Biomedicines 3:1, pages 71-88.
Crossref
Crossref
Benjamin C. MoraNeil E. FleshnerLaurence H. KlotzVasundara Venkateswaran. (2015) The Effects of Serum from Prostate Cancer Patients with Elevated Body Mass Index on Prostate Cancer Cells in Vitro. Lipid Insights 8, pages LPI.S23135.
Crossref
Crossref
Eleni Efstathiou, Mark Titus, Sijin Wen, Anh Hoang, Maria Karlou, Robynne Ashe, Shi Ming Tu, Ana Aparicio, Patricia Troncoso, James Mohler & Christopher J. Logothetis. (2015) Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer. European Urology 67:1, pages 53-60.
Crossref
Crossref
Fei Lian, Nitya V. Sharma, Josue D. Moran & Carlos S. Moreno. (2015) The biology of castration-resistant prostate cancer. Current Problems in Cancer 39:1, pages 17-28.
Crossref
Crossref
Michael G. DoranDaniel E. SprattJohn WongvipatDavid UlmertBrett S. CarverCharles L. SawyersMichael J. Evans. (2014) Cabozantinib Resolves Bone Scans in Tumor-Naïve Mice Harboring Skeletal Injuries. Molecular Imaging 13:8, pages 7290.2014.00026.
Crossref
Crossref
T Karantanos, P G Corn & T C Thompson. (2013) Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches. Oncogene 32:49, pages 5501-5511.
Crossref
Crossref
Holly M. Nguyen, Nazanin Ruppender, Xiaotun Zhang, Lisha G. Brown, Ted S. Gross, Colm Morrissey, Roman Gulati, Robert L. Vessella, Frauke Schimmoller, Dana T. Aftab & Eva Corey. (2013) Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling. PLoS ONE 8:10, pages e78881.
Crossref
Crossref
Andreas Varkaris, Sanchaika Gaur, Nila U. Parikh, Jian H. Song, Farshid Dayyani, Jung-Kang Jin, Christopher J. Logothetis & Gary E. Gallick. (2013) Ligand-independent activation of MET through IGF-1/IGF-1R signaling. International Journal of Cancer 133:7, pages 1536-1546.
Crossref
Crossref
Ah-Ng KongJames Cardelli, David Coleman & Katherine Crew. 2013. Inflammation, Oxidative Stress, and Cancer. Inflammation, Oxidative Stress, and Cancer
355
386
.
Luca Vanella, Claudia Di Giacomo, Rosaria Acquaviva, Ignazio Barbagallo, Giovanni Li Volti, Venera Cardile, Nader Abraham & Valeria Sorrenti. (2013) Effects of Ellagic Acid on Angiogenic Factors in Prostate Cancer Cells. Cancers 5:4, pages 726-738.
Crossref
Crossref
FRANK JACOBSEN, SHARAD NOURAIE ASHTIANI, PIERRE TENNSTEDT, HANS HEINZER, RONALD SIMON, GUIDO SAUTER, HÜSEYIN SIRMA, MARIA CHRISTINA TSOURLAKIS, SARAH MINNER, THORSTEN SCHLOMM & UWE MICHL. (2013) High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer. Experimental and Therapeutic Medicine 5:1, pages 102-106.
Crossref
Crossref
Farshid Dayyani, Nila U. Parikh, Andreas S. Varkaris, Jian H. Song, Shhyam Moorthy, Tanushree Chatterji, Sankar N. Maity, Adam R. Wolfe, Joan M. Carboni, Marco M. Gottardis, Christopher J. Logothetis & Gary E. Gallick. (2012) Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways. PLoS ONE 7:12, pages e51189.
Crossref
Crossref
Jo Tucker, Caroline Jochems, James Gulley, Jeffrey Schlom & Kwong Tsang. (2012) Immunotherapy: Shifting the Balance of Cell-Mediated Immunity and Suppression in Human Prostate Cancer. Cancers 4:4, pages 1333-1348.
Crossref
Crossref
Jianqing Lin & William K. Kelly. (2012) Targeting Angiogenesis as a Promising Modality for the Treatment of Prostate Cancer. Urologic Clinics of North America 39:4, pages 547-560.
Crossref
Crossref